deamidation raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
Solid tirzepatide is handled as a lyophilised, hygroscopic peptide powder that should be kept desiccated, protected from light, and stored frozen, typically at or below minus twenty degrees Celsius for long-term retention. Material left at ambient temperature for extended periods can take up moisture, which promotes aggregation and deamidation. Commercial liquid presentations are kept refrigerated between two and eight degrees Celsius and are not frozen. Reconstituted laboratory solutions are generally held cold and used within a short window because hydrolysis and oxidation continue slowly in solution.
Identity and purity are usually established with reversed-phase high-performance liquid chromatography for the main peak and with mass spectrometry for the observed molecular mass. Peptide mapping after enzymatic digestion confirms the primary sequence, while amino acid analysis provides a quantitative composition check. Size-exclusion chromatography and ion-exchange chromatography are used to look for aggregates and charge variants. Water content, residual solvents, and counter-ion content are measured separately, since a lyophilised powder is often reported on an as-is basis unless a correction is applied.
Tirzepatide is a synthetic peptide that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The molecule contains 39 amino acids and features a C20 fatty diacid moiety attached via a linker, which promotes albumin binding and extends its circulating half-life. Its sequence incorporates non-natural amino acids and modifications that reduce susceptibility to degradation by dipeptidyl peptidase-4. This dual receptor activity distinguishes it from selective GLP-1 receptor agonists.
The GIP receptor is expressed in pancreatic islets, adipose tissue, and the central nervous system, while GLP-1 receptors are found in pancreatic islets, the gastrointestinal tract, and the brain. Activation of both receptors can enhance glucose-dependent insulin secretion and reduce glucagon release. The relative contribution of each receptor to the overall pharmacological effect remains an area of ongoing investigation. Preclinical studies suggest that GIP receptor agonism may modulate appetite and energy balance, but the precise mechanisms in humans are not fully established.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilised solid, may form a loose cake |
| Solubility class | Soluble in water | Practically insoluble in nonpolar solvents |
| Storage temperature, solid | -20 °C or below | Desiccated and protected from light |
| Storage temperature, liquid | 2-8 °C | Refrigerated, not frozen |
| Typical identity method | LC-MS | Observed mass compared with calculated mass |
Recommended storage for reference material is a freezer at approximately -20 degrees Celsius, protected from light and moisture. Commercial injectable presentations are stored refrigerated between 2 and 8 degrees Celsius and must not be frozen. Product labelling generally permits a limited period at controlled room temperature once dispensed, with the exact window depending on the presentation. Repeated temperature cycling is avoided because it can promote aggregation or deamidation of the peptide chain.
Identity and purity are assessed by reversed-phase high-performance liquid chromatography, with mass confirmation by electrospray ionisation mass spectrometry. Peptide mapping after enzymatic digestion verifies the primary sequence. Size-exclusion chromatography quantifies aggregates, while circular dichroism provides a secondary-structure fingerprint. Bioanalytical quantification in plasma uses immunoassay or LC-MS/MS. Reported purity for research-grade lots is commonly 95 percent or higher, and residual water content is checked by Karl Fischer titration.
Structural work on the molecule centers on a C20 fatty diacid moiety attached through a linker to the peptide backbone. This side chain promotes reversible binding to serum albumin, which slows renal clearance and supports a prolonged action profile. The peptide backbone incorporates aminoisobutyric acid substitutions that limit recognition by digestive enzymes. Together these modifications produce a molecule that is stable enough for subcutaneous delivery but still dependent on careful manufacturing control. Analytical characterization of the active pharmaceutical ingredient typically follows the conventions used for other synthetic peptides.
Tirzepatide is a synthetic peptide composed of 39 amino acids. It acts as a dual agonist at two incretin receptors, the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. The molecule was designed by modifying the native sequence of glucose-dependent insulinotropic polypeptide to improve metabolic stability and extend its circulation time. Its structure includes several non-natural amino acid residues and a fatty acid side chain. These features distinguish it from earlier single-receptor incretin analogs studied in the same period.
The compound first appeared in the scientific literature as an investigational agent for type 2 diabetes. Clinical development proceeded through phase 1, phase 2, and phase 3 programs that measured glycemic control as a primary endpoint while recording body weight as a secondary outcome. Regulatory approval in the United States followed in 2022 for glycemic control, and a separate indication for chronic weight management was added later. Subsequent trials have examined cardiovascular outcomes in adults with elevated cardiovascular risk. Debates continue over how much of the observed effect derives from each receptor arm.
== India retail reforms == Until 2011, Indian central government denied foreign direct investment (FDI) in multi-brand Indian retail, forbidding foreign groups from any ownership in supermarkets, convenience stores or any retail outlets, to sell multiple products from different brands directly to Indian consumers. The government of Manmohan Singh, prime minister, announced on 24 November 2011 the following:
Water (H2O) is a polar inorganic compound. At room temperature it is a tasteless and odorless liquid, nearly colorless with a hint of blue. The simplest hydrogen chalcogenide, it is by far the most studied chemical compound and is sometimes described as the "universal solvent" for its ability to dissolve more substances than any other liquid, though it is poor at dissolving nonpolar substances. This allows it to be the "solvent of life": indeed, water as found in nature almost always includes various dissolved substances, and special steps are required to obtain chemically pure water. Water is the only common substance to exist as a solid, liquid, and gas in normal terrestrial conditions.
=== EC 2.7.6: Diphosphotransferases === EC 2.7.6.1: ribose-phosphate diphosphokinase EC 2.7.6.2: thiamine diphosphokinase EC 2.7.6.3: 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine diphosphokinase EC 2.7.6.4: nucleotide diphosphokinase EC 2.7.6.5: GTP diphosphokinase
Sources: en.wikipedia.org
=== Tracking of Cell Movement in Developmental Biology === EosFP has been used to track cell movements during embryonic development of Xenopus laevis. At the two-cell/ early gastrula stage, capped mRNA coding for a dimeric EosFP (d2EosFP) was injected into cells and locally photoconverted using fluorescence microscopy. These fluorescent embryos demonstrated the dynamics of cell movement during neurulation. EosFP was found in part of the notochord which shows the possibility of EosFP to be used in fate-mapping experiments.
==== Developing SASO ==== Following the 1968 NUSAS conference in Johannesburg, many of its members attended a July 1968 conference of the University Christian Movement at Stutterheim. There, the black African members decided to hold a December conference to discuss the formation of an independent black student group. The South African Students' Organisation (SASO) was officially launched at a July 1969 conference at the University of the North; there, the group's constitution and basic policy platform were adopted. The group's focus was on the need for contact between centres of black student activity, including through sport, cultural activities, and debating competitions. Though Biko played a substantial role in SASO's creation, he sought a low public profile during its early stages, believing that this would strengthen its second level of leadership, such as his ally Barney Pityana. Nonetheless, he was elected as SASO's first president; Pat Matshaka was elected vice president and Wuila Mashalaba elected secretary. Durban became its de facto headquarters.
=== Gr–Gu === Sam Granick (1909–1977). American biochemist at the Rockefeller University, known for his studies of ferritin and iron metabolism. Member Natl. Acad. Sci. USA. David E. Green (1910–1983). American biochemist at the University of Wisconsin, pioneer in the study of enzymes involved in oxidative phosphorylation. Member Natl. Acad. Sci. USA. Rowena Green Matthews (b. 1938). American biochemist at the University of Michigan Ann Arbor, working on the role of organic cofactors of enzymes, especially folic acid and cobalamin. Member Natl. Acad. Sci. USA. Lewis Joel Greene (b. 1934), American-Brazilian biochemist at the University of São Paulo, known for studies of protein chemistry. François Gros (1925–2022). French biologist and pioneer of cellular biochemistry at the French Academy of Sciences. Kun-Liang Guan (b. 1963). Chinese-American biochemist at the University of Michigan who works on gene regulation. F. Peter Guengerich (b. 1949). Biochemist and toxicologist at Vanderbilt University, working on cytochromes P450, DNA damage and carcinogenesis, and drug metabolism. Note. His personal Wikipedia page is very uninformative. Joan Guinovart (1947–2025). Spanish biochemist at the Institute for Research in Biomedicine (IRB Barcelona) known for studies of glycogen. Irwin Gunsalus (1912–2008). American biochemist at the University of Illinois, who discovered lipoic acid. He coauthored The Bacteria: A Treatise on Structure and Function with Roger Y. Stanier, a highly influential five-volume work. Member Natl. Acad. Sci. USA. Herbert Gutfreund FRS (1921–2021).
Hexin Instrument Co., Ltd (Guangzhou, China) commercialized a portable ion trap mass spectrometer DT-100 in 2017 for VOC monitoring. The mass spectrometer employs a VUV photo ionization source and a digital linear ion trap as mass analyzer. With an overall weight of 13 kg and size of 350 x 320 x 190 mm3 including the rechargeable Li battery. The specification includes a mass range of 20–500 Th for both MS and MS2, and mass resolving resolution of 0.3 Th (FWHM) at 106 Th.
Sources: en.wikipedia.org
It is normally kept frozen, desiccated, and away from light, with brief warming to room temperature before opening to limit condensation. Repeated freeze-thaw cycles are avoided because they stress the peptide. Once in solution, the material is held cold and used promptly.
Mass spectrometry gives the observed molecular mass, which is compared with the calculated value for the expected sequence. Reversed-phase chromatography shows retention behaviour and main peak purity. Peptide mapping adds sequence-level confirmation when the question requires it.
Typical entries include appearance, chromatographic purity as area percent, observed mass, water or residual solvent content, and the analytical methods used. The document reflects the lot tested and the laboratory that performed the work. It does not by itself establish that the delivered vial matches the tested lot.
It activates both GIP and GLP-1 receptors. This dual action differentiates it from selective GLP-1 agonists.